Cover Image
市場調查報告書

MediPoint:四肢重建 - 全球市場的分析與預測

MediPoint: Extremity Reconstruction - Global Analysis and Market Forecasts

出版商 GlobalData 商品編碼 353075
出版日期 內容資訊 英文 397 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:四肢重建 - 全球市場的分析與預測 MediPoint: Extremity Reconstruction - Global Analysis and Market Forecasts
出版日期: 2015年11月17日 內容資訊: 英文 397 Pages
簡介

全球四肢重建市場,是到2021年可望成長,充滿了活力的10億美元市場。市場推動因素為高齡人口的增加,關節炎的盛行率劇增,四肢植入設備的適應擴大,選擇活動性生活方式的患者偏好等。

本報告提供全球四肢重建市場相關調查分析,以主要十大市場 (美國、法國、德國、義大利、西班牙、英國、日本、中國、印度、巴西) 為焦點,提供引進、課題、市場動態、競爭情形、上市、開發中產品、現在、新興企業、預測等系統性資訊。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 概要
  • 治療趨勢
  • 市場進入
  • 崇尚名牌
  • 法規
  • 償付
  • 產品回收
  • M&A
  • 經濟影響

第4章 未滿足需求

  • 肩關節置換
  • 肘關節置換
  • 手腕關節置換
  • 指關節置換
  • 腳踝關節重建

第5章 推動市場要素,障礙,機會

  • 推動因素
  • 障礙
  • 機會

第6章 競爭評估

  • 肩關節置換
  • 肘關節置換
  • 手腕關節置換
  • 指關節置換
  • 腳踝關節重建

第7章 開發平台評估

  • 概要
  • 產品簡介

第8章 值得注意的臨床實驗

第9章 現在、未來的企業

  • 概要
  • 企業策略趨勢
  • Acumed
  • Arthrex
  • Corin Group
  • DePuy Synthes (Johnson & Johnson)
  • DJO Global
  • Exactech
  • Integra LifeSciences
  • 京瓷醫學
  • Lima Corporate
  • Smith & Nephew
  • Stryker
  • Tornier
  • Wright Medical Group
  • Zimmer Biomet Holdings
  • 其他的企業

第10章 市場預測

  • 企業的市場佔有率
  • 各市場部門
  • 各地區

第11章 附錄

圖表

目錄
Product Code: GDME0219MAR

The global extremity reconstruction market, which covers implant devices for the shoulder, elbow, wrist, digits, and ankle joints, is a billion-dollar market expected to grow through 2021. The growing global aging population, rising prevalence of arthritis, and expanding indications for extremity implant devices, as well as patient preference to maintain an active lifestyle, are expected to drive growth in the extremity replacement market through the forecast period. Emerging extremity implant technologies focus on recreating patient anatomy and natural joint function. Additionally, manufacturers focus on less invasive implant designs to accommodate future revision procedures.

This report examines extremity implant device adoption and challenges faced by current competitors in the 10 major markets (10MM): US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil. The analysis also identifies unmet needs in the market, specifies the major drivers and barriers to device adoption, provides insight into marketed and pipeline products, and provides an understanding of physician perception and outlook with an overall emphasis on current and future industry trends in the 10MM.

Highlights

Key Questions Answered

  • What is the current and future extremity reconstruction market outlook in the developed and emerging markets? What trends are affecting the global market?
  • Which are the key, high growth markets that extremity implant manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
  • What are the unmet needs with extremity reconstruction products currently on the market? How will emerging technologies fulfill these unmet needs?
  • What clinical factors and technical specifications influence a physician to use one implant device over another? What is physician perception and market outlook of extremity reconstruction?
  • What are the challenges and complications of extremity reconstruction that have hindered widespread adoption?
  • With developing the next-generation of extremity implant products, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global extremity reconstruction market?

Scope

  • Annualized total extremity reconstruction market revenue by type of device, direct and indirect costs of disease, procedure trends, and market outlooks by country through 2021.
  • Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.
  • Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and extremity implant products in development.
  • Analysis of the current and future market competition in the global extremity reconstruction market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

  • "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading orthopedic surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview
  • 3.2. Procedure Trends
    • 3.2.1. Global Overview
    • 3.2.2. By Country
  • 3.3. Market Access
    • 3.3.1. Purchasing Decisions
    • 3.3.2. Adoption
  • 3.4. Brand Loyalty
  • 3.5. Regulation
    • 3.5.1. US
    • 3.5.2. 5EU
    • 3.5.3. APAC
    • 3.5.4. South America
  • 3.6. Reimbursement
    • 3.6.1. US
    • 3.6.2. 5EU
    • 3.6.3. APAC
    • 3.6.4. South America
  • 3.7. Product Recalls
  • 3.8. Mergers and Acquisitions
    • 3.8.1. Wright Medical Merges with Tornier in $3.3 Billion All-Stock Deal (October 2015)
    • 3.8.2. Integra LifeSciences to Acquire Total Ankle Replacement Portfolio from Tornier N.V. (September 2015)
    • 3.8.3. Zimmer Acquires Biomet in $13.35 Billion Deal (June 2015)
    • 3.8.4. Teijin Acquires Nakashima Medical for JPY 1.5 Billion (April 2015)
    • 3.8.5. Stryker Acquires Small Bone Innovations for $375m (August-September 2014)
    • 3.8.6. Wright Medical Acquires OrthoPro for $36m (February 2014)
    • 3.8.7. Wright Medical Acquires Solana Surgical for $90m (January 2014)
    • 3.8.8. Wright Medical Acquires Biotech International for $80m (November 2013)
    • 3.8.9. Johnson & Johnson Acquires Synthes for $19.7 Billion (June 2012)
    • 3.8.10. Integra LifeSciences Acquires Ascension Orthopedics for $65m (September 2011)
  • 3.9. Economic Impact
    • 3.9.1. Arthritis
    • 3.9.2. High Revision Rates

4. Unmet Needs

  • 4.1. Shoulder Replacement
    • 4.1.1. Durable Glenoid Components
    • 4.1.2. Augmented Glenoid Components
    • 4.1.3. Grammont-Style Versus Frankle-Style
    • 4.1.4. Addressing Complications of Reverse Shoulder Replacement
    • 4.1.5. Bone-Sparing Stemless Designs: Pros and Cons
    • 4.1.6. Revision Systems
    • 4.1.7. Long-Term Follow-Up
    • 4.1.8. Patient Awareness in Emerging Markets
    • 4.1.9. Accurate Glenoid Component Positioning
    • 4.1.10. Implant Sizing for APAC Patients
  • 4.2. Elbow Replacement
    • 4.2.1. Implant Survival and Fixation Techniques
    • 4.2.2. Implant Positioning
    • 4.2.3. Long-Term Follow-Up
  • 4.3. Wrist Replacement
    • 4.3.1. Long-Term Clinical Data
    • 4.3.2. Limited Product Offerings
    • 4.3.3. Failure and Revision Rates
    • 4.3.4. Physiological Wrist Movement
    • 4.3.5. Carpal Component Fixation
  • 4.4. Digits Replacement
    • 4.4.1. Pyrocarbon Implant Durability and Fixation
    • 4.4.2. Improved Patient Functionality
  • 4.5. Ankle Replacement
    • 4.5.1. Long-Term Follow-Up
    • 4.5.2. Commitment to Medical Education
    • 4.5.3. Advanced Biological Fixation
    • 4.5.4. Minimal Bone Resection
    • 4.5.5. Mobile-Bearing Versus Fixed-Bearing
    • 4.5.6. Bespoke Instrumentation
    • 4.5.7. Custom Prostheses
    • 4.5.8. Revision Components

5. Market Drivers, Barriers, and Opportunities

  • 5.1. Driver: Rising Joint Disease Prevalence
    • 5.1.1. Sport-Related Injuries
    • 5.1.2. Trauma
    • 5.1.3. Aging
    • 5.1.4. Obesity
  • 5.2. Driver: Increased Patient Awareness
  • 5.3. Driver: Corporate Promotions and Continuing Medical Education
  • 5.4. Driver: Expected Launch of CE-Marked Devices
  • 5.5. Driver: Expanded Indications of Reverse Shoulder Replacement
  • 5.6. Driver: Stemless Shoulder Implants in the EU
  • 5.7. Driver: Superiority of Ankle Replacment over Ankle Fusion
  • 5.8. Driver: Expanded Insurance Coverage for TAR
  • 5.9. Barrier: Medical Device Excise Tax
  • 5.10. Barrier: Postoperative Complications
  • 5.11. Barrier: Long Learning Curve
  • 5.12. Barrier: Alternatives to Total Joint Replacement
  • 5.13. Barrier: Shoulder Replacement Reimbursement
  • 5.14. Barrier: Preoperative Patient Selection for TAR
  • 5.15. Opportunity: Pyrocarbon
  • 5.16. Opportunity: Demand for a Comprehensive Reconstruction Portfolio
  • 5.17. Opportunity: Computer-Assisted Navigation and Patient-Specific Instrumentation
  • 5.18. Opportunity: Emerging Markets
  • 5.19. Opportunity: Capitalizing on Wrist Market Fragmentation
  • 5.20. Opportunity: TAR Expanded Indications
  • 5.21. Opportunity: Fixed-Bearing TAR Implants in the EU

6. Competitive Assessment

  • 6.1. Shoulder Replacement
    • 6.1.1. Overview
    • 6.1.2. Product Profiles - Anatomic Total Shoulder Replacement
    • 6.1.3. Product Profiles - Anatomic Stemless Total Shoulder Replacement
    • 6.1.4. Product Profiles - Reverse Total Shoulder Replacement
  • 6.2. Elbow Replacement
    • 6.2.1. Overview
    • 6.2.2. Product Profiles
  • 6.3. Wrist Replacement
    • 6.3.1. Overview
    • 6.3.2. Product Profiles
  • 6.4. Digits Replacement
    • 6.4.1. Overview
    • 6.4.2. Product Profiles
  • 6.5. Ankle Replacement
    • 6.5.1. Overview
    • 6.5.2. Product Profiles - Two-Component Fixed-Bearing
    • 6.5.3. Product Profiles - Three-Component Mobile-Bearing

7. Pipeline Assessment

  • 7.1. Overview
  • 7.2. Product Profiles
    • 7.2.1. AFT Proximal Humerus Fracture Prosthesis (Shoulder Options)
    • 7.2.2. Akilos Total Ankle System (Implants International)
    • 7.2.3. aSpire Total Shoulder Arthroplasty System (Shoulder Options)
    • 7.2.4. Comprehensive Nano Stemless Shoulder (Zimmer Biomet)
    • 7.2.5. Helical Conservative Shoulder Prosthesis (University of Missouri)
    • 7.2.6. INBONE Calcaneal Stem Implant (Wright Medical)
    • 7.2.7. Luna Stemless Humeral Prosthesis (Shoulder Options)
    • 7.2.8. PyroCarbon Modular Radial Head (Integra LifeSciences)
    • 7.2.9. NDSU Total Ankle Replacement Device (NDSU Research Foundation)
    • 7.2.10. Vantage Ankle System (Exactech)

8. Clinical Trials to Watch

  • 8.1. Overview
  • 8.2. Discovery Elbow Long-Term Survivorship Study
  • 8.3. Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Shoulder System
  • 8.4. An Observational Cohort Study Evaluating the Safety and Performance of Aequalis Resurfacing Head Implant in a Consecutive Series of Patients with Shoulder Arthroplasty
  • 8.5. Sidus(TM) Stem-Free Shoulder - A Multi-center, Prospective, Non-controlled Post Market Clinical Follow-up Study
  • 8.6. A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse Shoulder Prosthesis to the Univers II Shoulder Prosthesis in Patients with a Degenerative Joint Disease
  • 8.7. Prospective Post Market Clinical Follow-Up (PMCF) Study of the Zimmer Trabecular Metal Total Ankle
  • 8.8. Motec Versus Remotion Total Wrist Arthroplasty - A Prospective Randomized Study
  • 8.9. A Post-market Clinical Follow-up Study of the TITAN Reverse Shoulder System Used in Primary or Revision Total Shoulder Arthroplasty
  • 8.10. A Prospective Multi-Center Study of the Safety and Effectiveness of the Tornier Simpliciti Shoulder System in Shoulder Arthroplasty
  • 8.11. Retrospective and Prospective Clinical Outcomes Study of the Zimmer Nexel Total Elbow

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Trends in Corporate Strategy
  • 9.3. Acumed
    • 9.3.1. Overview
    • 9.3.2. Portfolio Assessment
    • 9.3.3. SWOT Analysis
  • 9.4. Arthrex
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment
    • 9.4.3. SWOT Analysis
  • 9.5. Corin Group
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment
    • 9.5.3. SWOT Analysis
  • 9.6. DePuy Synthes (Johnson & Johnson)
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment
    • 9.6.3. SWOT Analysis
  • 9.7. DJO Global
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment
    • 9.7.3. SWOT Analysis
  • 9.8. Exactech
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment
    • 9.8.3. SWOT Analysis
  • 9.9. Integra LifeSciences
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment
    • 9.9.3. SWOT Analysis
  • 9.10. Kyocera Medical Corporation
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment
    • 9.10.3. SWOT Analysis
  • 9.11. Lima Corporate
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment
    • 9.11.3. SWOT Analysis
  • 9.12. Smith & Nephew
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment
    • 9.12.3. SWOT Analysis
  • 9.13. Stryker
    • 9.13.1. Overview
    • 9.13.2. Portfolio Assessment
    • 9.13.3. SWOT Analysis
  • 9.14. Tornier
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment
    • 9.14.3. SWOT Analysis
  • 9.15. Wright Medical Group
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment
    • 9.15.3. SWOT Analysis
  • 9.16. Zimmer Biomet Holdings
    • 9.16.1. Overview
    • 9.16.2. Portfolio Assessment
    • 9.16.3. SWOT Analysis
  • 9.17. Other Players

10. Market Outlook

  • 10.1. Company Market Share
    • 10.1.1. Global Overview
    • 10.1.2. By Region
  • 10.2. By Market Segment
    • 10.2.1. Global Overview
    • 10.2.2. By Region
  • 10.3. By Geography
    • 10.3.1. Global Overview
    • 10.3.2. US
    • 10.3.3. France
    • 10.3.4. Germany
    • 10.3.5. Italy
    • 10.3.6. Spain
    • 10.3.7. UK
    • 10.3.8. Japan
    • 10.3.9. China
    • 10.3.10. India
    • 10.3.11. Brazil

11. Appendix

  • 11.1. Bibliography
  • 11.2. Abbreviations
  • 11.3. Methodology
    • 11.3.1. Overview
    • 11.3.2. Coverage
    • 11.3.3. Secondary Research
  • 11.4. Forecasting Methodology
  • 11.5. Physicians and Specialists Included in This Study
    • 11.5.1. Key Opinion Leaders
  • 11.6. Primary Research Summary
  • 11.7. About the Authors
    • 11.7.1. Analysts
    • 11.7.2. Global Head of Medical Devices
  • 11.8. About GlobalData
  • 11.9. Disclaimer

List of Tables

  • Table 1: Global Extremity Replacement Procedure Volumes, 2012-2021
  • Table 2: FDA Classifications - Extremity Joint Implants
  • Table 3: Medicare Coding Guide for Extremity Arthroplasty - 2015
  • Table 4: CPT Coding for Physician Payment in Extremity Arthroplasty - 2015
  • Table 5: Product Recalls (2014-2015)
  • Table 6: Mergers and Acquisitions (2011-2015)
  • Table 7: Direct and Indirect Costs of Arthritis
  • Table 8: Advantages and Disadvantages of Ankle Fusion and Total Ankle Replacement
  • Table 9: Product Profile - Univers II
  • Table 10: Product Profile - Global Advantage
  • Table 11: Product Profile - Global Fx
  • Table 12: Product Profile - Global AP
  • Table 13: Product Profile - Global Unite
  • Table 14: Product Profile - Foundation Shoulder System
  • Table 15: Product Profile - Turon
  • Table 16: Product Profile - Equinoxe
  • Table 17: Product Profile - SEVIIN
  • Table 18: Product Profile - TITAN Modular Shoulder System.
  • Table 19: Product Profile - SMR Modular Shoulder System
  • Table 20: Product Profile - Cofield 2
  • Table 21: Product Profile - Neer 3
  • Table 22: Product Profile - Promos Standard
  • Table 23: Product Profile - Solar Total Shoulder System
  • Table 24: Product Profile - ReUnion HA Fracture System
  • Table 25: Product Profile - Aequalis Primary
  • Table 26: Product Profile - Aequalis Fracture stem
  • Table 27: Product Profile - Affiniti
  • Table 28: Product Profile - Aequalis Ascend
  • Table 29: Product Profile - Ascend Flex Convertible Shoulder System
  • Table 30: Product Profile - Bigliani/Flatow
  • Table 31: Product Profile - Anatomical Shoulder System
  • Table 32: Product Profile - Comprehensive Total Shoulder System
  • Table 33: Product Profile - Comprehensive Fracture System
  • Table 34: Product Profile - Trabecular Metal
  • Table 35: Product Profile - Eclipse
  • Table 36: Product Profile - Simpliciti
  • Table 37: Product Profile - InSpyre
  • Table 38: Product Profile - Comprehensive Nano
  • Table 39: Product Profile - T.E.S.S. Anatomic
  • Table 40: Product Profile - Sidus Stem-Free Shoulder
  • Table 41: Product Profile - Univers Revers Shoulder Prosthesis
  • Table 42: Product Profile - Delta Xtend Reverse Shoulder System
  • Table 43: Product Profile - Reverse Shoulder Prosthesis (RSP)
  • Table 44: Product Profile - Equinoxe Reverse Shoulder System
  • Table 45: Product Profile - SMR Reverse
  • Table 46: Product Profile - Promos Reverse
  • Table 47: Product Profile - ReUnion RSA
  • Table 48: Product Profile - Aequalis Reversed II
  • Table 49: Product Profile - Aequalis Reversed Fracture
  • Table 50: Product Profile - Anatomical Reverse
  • Table 51: Product Profile - T.E.S.S. Reverse
  • Table 52: Product Profile - Comprehensive Reverse Shoulder
  • Table 53: Product Profile - Trabecular Metal Reverse
  • Table 54: Product Profile - Discovery Elbow
  • Table 55: Product Profile - Solar Total Elbow
  • Table 56: Product Profile - Latitude EV
  • Table 57: Product Profile - Coonrad-Morrey
  • Table 58: Product Profile - Nexel
  • Table 59: Other Marketed Elbow Replacement Implants
  • Table 60: Marketed Radial Head Replacement Implants
  • Table 61: Product Profile - Freedom Wrist
  • Table 62: Product Profile - Universal 2 Total Wrist
  • Table 63: Product Profile - ReMotion Total Wrist
  • Table 64: Product Profile - Motec Wrist
  • Table 65: Product Profile - Maestro Total Wrist
  • Table 66: Product Profile - MWP III Total Wrist
  • Table 67: Marketed Finger Digits Implants
  • Table 68: Product Profile - TNK
  • Table 69: Product Profile - Salto Talaris
  • Table 70: Product Profile - INBONE II Total Ankle
  • Table 71: Product Profile - INFINITY Total Ankle System
  • Table 72: Product Profile - Zimmer Trabecular Metal Total Ankle
  • Table 73: Product Profile - Zenith
  • Table 74: Product Profile - HINTEGRA Total Ankle Prosthesis
  • Table 75: Product Profile - BOX
  • Table 76: Product Profile - STAR
  • Table 77: Product Profile - Salto
  • Table 78: Product Profile - CCI Evolution
  • Table 79: Product Profile - AFT Proximal Humerus Fracture Prosthesis
  • Table 80: SWOT Analysis - AFT Proximal Humerus Fracture Prosthesis
  • Table 81: Product Profile - Akilos Total Ankle System
  • Table 82: SWOT Analysis - Akilos Total Ankle System
  • Table 83: Product Profile - aSpire Total Shoulder System
  • Table 84: SWOT Analysis - aSpire Total Shoulder System
  • Table 85: Product Profile - Comprehensive Nano Stemless Shoulder
  • Table 86: SWOT Analysis - Comprehensive Nano Stemless Shoulder
  • Table 87: Product Profile - Helical Conservative Shoulder Prosthesis
  • Table 88: SWOT Analysis - Helical Conservative Shoulder Prosthesis
  • Table 89: Product Profile - INBONE Calcaneal Stem
  • Table 90: SWOT Analysis - INBONE Calcaneal Stem
  • Table 91: Product Profile - Luna
  • Table 92: SWOT Analysis - Luna
  • Table 93: Product Profile - PyroCarbon Modular Radial Head
  • Table 94: SWOT Analysis - PyroCarbon Modular Radial Head
  • Table 95: Product Profile - NDSU Total Ankle Replacement
  • Table 96: SWOT Analysis - NDSU Total Ankle Replacement
  • Table 97: Product Profile - Vantage Ankle System
  • Table 98: Discovery Elbow Long-Term Survivorship Study
  • Table 99: Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Shoulder System
  • Table 100: An Observational Cohort Study Evaluating the Safety and Performance of Aequalis Resurfacing Head Implant in a Consecutive Series of Patients with Shoulder Arthroplasty
  • Table 101: Sidus(TM) Stem-Free Shoulder - A Multi-center, Prospective, Non-controlled Post Market Clinical Follow-up Study
  • Table 102: A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse Shoulder Prosthesis to the Univers II Shoulder Prosthesis in Patients with a Degenerative Joint Disease
  • Table 103: Prospective Post Market Clinical Follow-Up (PMCF) Study of the Zimmer Trabecular Metal Total Ankle
  • Table 104: Motec Versus Remotion Total Wrist Arthroplasty - A Prospective Randomized Study
  • Table 105: A Post-market Clinical Follow-up Study of the TITAN Reverse Shoulder System Used in Primary or Revision Total Shoulder Arthroplasty
  • Table 106: A Prospective Multi-Center Study of the Safety and Effectiveness of the Tornier Simpliciti Shoulder System in Shoulder Arthroplasty
  • Table 107: Retrospective and Prospective Clinical Outcomes Study of the Zimmer Nexel Total Elbow
  • Table 108: Company Profile - Acumed
  • Table 109: SWOT Analysis - Acumed
  • Table 110: Company Profile - Arthrex
  • Table 111: SWOT Analysis - Arthrex
  • Table 112: Company Profile - Corin Group
  • Table 113: SWOT Analysis - Corin Group
  • Table 114: Company Profile - DePuy
  • Table 115: SWOT Analysis - DePuy
  • Table 116: Company Profile - DJO
  • Table 117: SWOT Analysis - DJO
  • Table 118: Company Profile - Exactech
  • Table 119: SWOT Analysis - Exactech
  • Table 120: Company Profile - Integra LifeSciences
  • Table 121: SWOT Analysis - Integra LifeSciences
  • Table 122: Company Profile - KMC
  • Table 123: SWOT Analysis - KMC
  • Table 124: Company Profile - Lima
  • Table 125: SWOT Analysis - Lima
  • Table 126: Company Profile - Smith & Nephew
  • Table 127: SWOT Analysis - Smith & Nephew
  • Table 128: Company Profile - Stryker
  • Table 129: SWOT Analysis - Stryker
  • Table 130: Company Profile - Tornier
  • Table 131: SWOT Analysis - Tornier
  • Table 132: Company Profile - Wright Medical
  • Table 133: SWOT Analysis - Wright Medical
  • Table 134: Company Profile - Zimmer Biomet
  • Table 135: SWOT Analysis - Zimmer Biomet
  • Table 136: Other Players in the Global Extremity Replacement Market
  • Table 137: Global Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 138: Global Market Value Forecast by Market Segment for Shoulder Replacement, $m, 2012-2021
  • Table 139: 5EU Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 140: APAC Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 141: Total Sales Volume by Country for Extremity Replacement Implants, Number of Units, 2012-2021
  • Table 142: Global Market Value Forecast by Country for Extremity Replacement, $m, 2012-2021
  • Table 143: US Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 144: France Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 145: Germany Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 146: Italy Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 147: Spain Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 148: UK Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 149: Japan Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 150: China Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 151: India Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Table 152: Brazil Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021

List of Figures

  • Figure 1: US Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 2: US Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 3: US Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 4: US Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 5: France Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 6: France Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 7: France Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 8: France Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 9: Germany Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 10: Germany Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 11: Germany Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 12: Germany Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 13: Italy Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 14: Italy Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 15: Italy Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 16: Italy Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 17: Spain Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 18: Spain Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 19: Spain Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 20: Spain Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 21: UK Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 22: UK Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 23: UK Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 24: UK Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 25: Japan Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 26: Japan Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 27: Japan Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 28: Japan Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 29: China Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 30: China Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 31: China Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 32: China Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 33: India Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 34: India Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 35: India Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 36: India Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 37: Brazil Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 38: Brazil Procedure Volume Comparison by Market Segment, 2014 and 2021
  • Figure 39: Brazil Shoulder Replacement Procedure Volume Forecast by Segment, 2012-2021
  • Figure 40: Brazil Shoulder Replacement Procedure Volume Comparison by Segment, 2014 and 2021
  • Figure 41: Global Company Market Shares for Extremity Replacement, 2014
  • Figure 42: US Company Market Shares for Extremity Replacement, 2014
  • Figure 43: 5EU Company Market Shares for Extremity Replacement, 2014
  • Figure 44: France Company Market Shares for Extremity Replacement, 2014
  • Figure 45: Germany Company Market Shares for Extremity Replacement, 2014
  • Figure 46: Italy Company Market Shares for Extremity Replacement, 2014
  • Figure 47: Spain Company Market Shares for Extremity Replacement, 2014
  • Figure 48: UK Company Market Shares for Extremity Replacement, 2014
  • Figure 49: APAC Company Market Shares for Extremity Replacement, 2014
  • Figure 50: Japan Company Market Shares for Extremity Replacement, 2014
  • Figure 51: China Company Market Shares for Extremity Replacement, 2014
  • Figure 52: India Company Market Shares for Extremity Replacement, 2014
  • Figure 53: Brazil Company Market Shares for Extremity Replacement, 2014
  • Figure 54: Global Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 55: Global Market Value Forecast by Market Segment for Shoulder Replacement, $m, 2012-2021
  • Figure 56: 5EU Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 57: APAC Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 58: Global Sales Volume for Extremity Replacement Implants, Number of Units, 2012-2021
  • Figure 59: Global Market Value Forecast by Country, $m, 2012-2021
  • Figure 60: Global Market Share Comparison by Country, 2014 and 2021
  • Figure 61: US Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 62: US Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 63: France Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 64: France Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 65: Germany Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 66: Germany Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 67: Italy Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 68: Italy Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 69: Spain Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 70: Spain Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 71: UK Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 72: UK Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 73: Japan Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 74: Japan Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 75: China Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 76: China Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 77: India Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 78: India Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 79: Brazil Market Value Forecast by Market Segment for Extremity Replacement, $m, 2012-2021
  • Figure 80: Brazil Market Value Comparison by Market Segment for Extremity Replacement, 2014 and 2021
  • Figure 81: Primary Research Participants by Country
Back to Top